<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>İmmünsupresif İlaç Güvenliği &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/immunsupresif-ilac-guvenligi/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 23 Nov 2025 08:47:49 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>İmmünsupresif İlaç Güvenliği &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Linking Pharmacovigilance and Genetics in Breast Cancer Risk</title>
		<link>https://bioengineer.org/linking-pharmacovigilance-and-genetics-in-breast-cancer-risk/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 23 Nov 2025 08:47:31 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Farmakovijilans ve Genetik]]></category>
		<category><![CDATA[İmmünsupresif İlaç Güvenliği]]></category>
		<category><![CDATA[Kişiselleştirilmiş Tıp]]></category>
		<category><![CDATA[Meme Kanseri Risk Faktörleri]]></category>
		<category><![CDATA[Otoimmün Hastalıklar ve Tedavi]]></category>
		<guid isPermaLink="false">https://bioengineer.org/linking-pharmacovigilance-and-genetics-in-breast-cancer-risk/</guid>

					<description><![CDATA[In a groundbreaking study published in the Journal of Translational Medicine, researchers led by Song, N., Xi, X., and Zhang, K. have unveiled critical insights into the intersection of pharmacovigilance and genetics. Their research focuses on understanding the complex relationship between autoimmune diseases, the medications used to treat them, and the subsequent risk of breast [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">300186</post-id>	</item>
	</channel>
</rss>
